samedan logo
 
 
spacer
home > pmps > summer 2021 > mitigating compressed air risks in pharma manufacturing industry 4.0 technologies are being used to improve energy usage and cut costs, and compressed air is just one of the areas that the evolution is being seen.
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Mitigating Compressed Air Risks in Pharma Manufacturing Industry 4.0 technologies are being used to improve energy usage and cut costs, and compressed air is just one of the areas that the evolution is being seen.

The pharmaceutical industry is one of the most regulated in the world, with manufacturing processes controlled by GMP guidelines, the European Pharmacopoeia, the FDA, and the ICH. While these regulations cover even the smallest technical aspects of pharma production, they pay comparatively little attention to the use of compressed air in these manufacturing environments. For example, the European Pharmacopoeia only focuses on air for medical applications and, in this context, only makes a distinction in respect of artificial air for medical applications.

Nevertheless, compressed air is used in a range of pharma applications, from laboratories to extruders, bottling plants, tablet presses, and packaging processes. In many of these processes, compressed air will come into direct contact with products, such as when drying equipment parts, transporting substances through tubes, and when compressed air is used as a pressure blanket for solutions in tanks. Compressed air is also used for equipment control purposes in manufacturing production lines too, for example, for pneumatically opening valves. Many of these processes operate 24/7 as well, so ensuring the right compressor is specified is critical.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr David Bruchof is Product Manager for Oil-Free Industrial Compressors at CompAir. Having studied Mechanical Engineering at RWTH Aachen University, Germany, he earned his Doctorate at the University of Stuttgart, Germany. He is a specialist in oil-free screw technology and the considerations that need to be given when specifying compressed air systems for production sensitive environments, such as pharma manufacturing facilities.

david.bruchof@gardnerdenver.com
spacer
Dr David Bruchof
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Thermo Fisher Scientific Adds Patterned Microchip-based Technology to Liquid Chromatography Portfolio

PHILADELPHIA – ASMS 2021 – (November 1, 2021) – Thermo Fisher Scientific, the world leader in serving science, today announced its acquisition of Belgium-based PharmaFluidics, the developer of the μPAC range of micro-chip-based chromatography column.
More info >>

White Papers

Translating Cancer Genomics Into A Personalised Approach For Cancer Patients

PRA Health Sciences (PRA)

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement